Skip to main content
Caplight Logo









Tioga Pharmaceuticals

Tioga Pharmaceuticals

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://tiogapharma.com/

Last Round

Series B

Apr 10, 2012

Total Funding Raised

$57M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Tioga Pharmaceuticals is a pharmaceutical company that develops non-hormonal therapies for women's health, with a lead program for managing vasomotor symptoms associated with menopause.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

non-hormonal therapyhot flashesvasomotor symptomswomen's healthmenopause treatmentkappa-opioid receptor agonistKOR agonistVMSasimadolineclinical-stage pharmasmall molecule drugpharma licensingbiotechnology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tioga Pharmaceuticals Comparables

Compare Tioga Pharmaceuticals with similar companies based on industry and business-model similarity.

Tioga Pharmaceuticals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MenoGeniX, Inc.
87%
Estrigenix Therapeutics
86%
Bayer AG
74%

Tioga Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BApr 10, 2012
Series A ExtensionFeb 17, 2010
DebtOct 26, 2009
DebtMay 27, 2009
Series AJan 9, 2006

Tioga Pharmaceuticals Investors

Notable investors and investment history

Tioga Pharmaceuticals investors
InvestorRounds
New Leaf Venture PartnersSeries A, Series A Extension
Thomas, McNerney & PartnersSeries B
Genesys CapitalSeries B, Series A Extension
Forward VenturesSeries A Extension, Series A
BB Biotech VenturesSeries A, Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 253% MoM, reaching 728.

  • Jul 9, 2025

    Monthly visitors increased 212% MoM.

Tioga Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Tioga Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Tioga Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range3
Year Founded2005
Last FundingApr 10, 2012

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?